LY06006 clinical trials
Also written LY06006.
How each study uses LY06006 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- LY06006
- 3
Studies by the year they started
4 studies that test it; most in 2018 (1)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Luye Pharma Group Ltd. (3) · Shandong Boan Biotechnology Co., Ltd (1)
Studies
Open first, then newest update. How each study uses LY06006 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- A Pharmacokinetic Similarity Study in Healthy Male Subjects to Evaluate Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of LY06006 Versus US-Prolia and EU-Prolia by Single-dose Subcutaneous InjectionCompletedPhase 1Shandong Boan Biotechnology Co., LtdNCT06095427Written as LY06006 (Denosumab Biosimilar)
- A Study to Evaluate the Efficacy and Safety of LY06006 in Postmenopausal Women With Osteoporosis at High Risk for FractureStatus unknownPhase 3Luye Pharma Group Ltd.NCT05060406Written as LY06006
- A Study to Evaluate LY06006 and Prolia in Healthy AdultsStatus unknownPhase 1Luye Pharma Group Ltd.NCT04973722Written as LY06006
- A Study to Evaluate the Denosumab in Healthy AdultsStatus unknownPhase 1Luye Pharma Group Ltd.NCT03427853Written as LY06006